Key facts
- It has raised $15.0M; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include Johnson & Johnson JJDC, Mayo Clinic Ventures, NYU Summer Launchpad, ATU Partners, American Society of Echocardiography — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for UltraSight
- ·The full record, as it builds
Funding rounds
No funding rounds for UltraSight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UltraSight
Operator of an artificial intelligence-powered cardiac ultrasound system intended to improve the quality and accessibility of cardiac care. The company's technology guides ultrasound operators, helping them to acquire quality images more quickly and easily, which can lead to earlier diagnosis and treatment of heart disease, enabling medical professionals to acquire timely and accurate cardiac ultrasound images anywhere.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2018
- Employees
- 39
- Website
- ultrasight.com/
- Ownership
- Privately Held (backing)
UltraSight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UltraSight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UltraSight in its N-PORT filings yet. We sweep new filings monthly.